Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Depreciation and Depletion (2022 - 2025)

Revolution Medicines has reported Depreciation and Depletion over the past 4 years, most recently at $2.1 million for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $2.1 million for Q4 2025, up 50.0% from a year ago — trailing twelve months through Dec 2025 was $7.4 million (up 21.31% YoY), and the annual figure for FY2025 was $7.4 million, up 19.35%.
  • Depreciation and Depletion for Q4 2025 was $2.1 million at Revolution Medicines, up from $2.0 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for RVMD hit a ceiling of $2.1 million in Q4 2025 and a floor of $900000.0 in Q1 2022.
  • Median Depreciation and Depletion over the past 4 years was $1.3 million (2023), compared with a mean of $1.4 million.
  • Peak annual rise in Depreciation and Depletion hit 50.0% in 2025, while the deepest fall reached 6.25% in 2025.
  • Revolution Medicines' Depreciation and Depletion stood at $1.2 million in 2022, then rose by 10.45% to $1.3 million in 2023, then increased by 7.69% to $1.4 million in 2024, then soared by 50.0% to $2.1 million in 2025.
  • The last three reported values for Depreciation and Depletion were $2.1 million (Q4 2025), $2.0 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.